Alzheimer's Disease and Dementia
Featured Topics
Lead story
Other featured articles
-
Advancing the Science of Recruitment for Inclusive Alzheimer’s Disease Clinical Trials
The roundtable will convene thought leaders and stakeholders across the clinical trials ecosystem to share insights on progress made, remaining gaps, and best practices from the field in advancing recruitment for inclusive Alzheimer’s clinical trials.
Posted in -
2024 Alzheimer’s Trial Recruitment Innovation Lab Fellowship Program — Application Closed
The University of Southern California (USC) announces an opening for a fellow to join the Alzheimer’s Trial Recruitment Innovation Lab (ATRIL) fellowship program in the fall of 2024.
Posted in -
Key USC Researchers’ Dementia Cost Model Aims to Help Patients, Families
Knowing the actual costs of dementia could help families plan their budgets and support needs, inform treatment and caregiving options, and shape health care policy.
Posted in -
Access to New Alzheimer’s Treatments Bogged Down by Medicare Policy
There are now two Alzheimer’s treatments with significant clinical benefit. It’s not clear how quickly patients will be able to benefit.
Posted in
About this section
Even small delays in the onset of Alzheimer's disease and dementia could have significant impacts for the patient, their family and caregivers, and the healthcare system more broadly. The Schaeffer Center's microsimulation models demonstrate there may be preventive measures we can take now to shape the nation's future health.
OUR EXPERTS ON ALZHEIMER'S DISEASE AND DEMENTIA PREVENTION
Our Work In Alzheimer's Disease and Dementia
-
Remote Blood Collection Shows Promise for Alzheimer’s Research
A new study shows promise for using remote blood collection to find participants for Alzheimer’s trials.
-
Reporting and Representation of Participant Demographic Information in Completed Alzheimer’s Disease Clinical Trials
Research findings highlight the need for improved recruitment strategies to include more diverse participants in Alzheimer’s clinical trials.
Categorized in -
Diagnoses and Treatment of Behavioral and Psychological Symptoms of Dementia Among Racially and Ethnically Diverse Persons Living with Dementia
Lower rates of behavioral and psychological symptoms of dementia diagnoses in non-white compared to white populations may indicate underdiagnosis in clinical settings of treatable conditions.
Categorized in -
Study Reveals Racial Disparities in Diagnosis and Drug Use for Dementia Symptoms
White and Hispanic people are most likely to be diagnosed with behavioral symptoms of dementia, but they’re also most likely to be treated with potentially harmful drugs, according to a new USC study.
Categorized in -
Medicare Can Follow Blazed Trails to Revitalize Alzheimer’s Care
If Medicare is allowed to step up to the challenge of Alzheimer’s, patients could receive affordable and good quality care as soon as their disease develops.
Categorized in -
Analysis of Agreement Between Measures of Subjective Cognitive Impairment and Probable Dementia in the National Health and Aging Trends Study
Subjective cognitive impairment was more prevalent than probable dementia
Categorized in